文献速递神经核医学

[18F]Florbetazine在阿尔茨海默病中的诊断效能:与[11C]PiB和[18F]Florbetapir的头对头比较

The diagnostic performance of [18F]Florbetazine in Alzheimer's disease: a head-to-head comparison to [11C]PiB and [18F]Florbetapir.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-04-04

研究纳入78名参与者,分FBZ-PiB亚组40例和FBZ-FBP亚组38例,比较[18F]Florbetazine(FBZ)与[11C]PiB及[18F]Florbetapir(FBP)PET的AD诊断效能。FBZ视觉判读诊断敏感度100%、特异度97%,与PiB和FBP完全一致;三种示踪剂全局SUVr对AD诊断准确率均完美,FBZ与PiB及FBP的SUVr强相关。

要点

  • FBZ PET视觉判读诊断敏感度100%、特异度97%,与PiB和FBP完全一致。
  • FBZ灰质摄取高于白质,灰白质对比度优于PiB和FBP。
  • 三种示踪剂全局SUVr对AD诊断准确率均完美,FBZ与PiB及FBP强相关。

核心结论

  • FBZ PET诊断效能与PiB和FBP相当,Aβ定量相关性极佳。
  • FBZ皮质摄取高、白质结合低,有利于临床视觉判读。

研究设计与样本

  • 共纳入78名参与者,FBZ-PiB亚组40例(健康对照9例、非AD痴呆9例、AD 22例),FBZ-FBP亚组38例(健康对照10例、非AD痴呆9例、轻度认知障碍1例、AD 18例)。
  • 所有图像由两名受训核医学医师视觉评估,并用全局及区域标准化摄取值比(SUVr)定量分析。

主要发现

  • FBZ视觉判读诊断敏感度100%、特异度97%,与PiB和FBP完全一致。
  • 阳性FBZ PET显示灰质摄取高于白质,皮质分布与PiB相似,灰白质对比度高于PiB(1.19(0.17) vs 1.11(0.15),P < 0.001)和FBP(1.27(0.24) vs 0.86(0.13),P < 0.001)。
  • 以全小脑为参考时,FBZ全局SUVr诊断AD的界值范围为0.99至1.38。
  • FBZ全局SUVr与PiB强相关(斜率=0.94,r=0.99,P < 0.001),与FBP强相关(斜率=1.74,r=0.95,P < 0.001)。

关键数值与推荐

  • FBZ视觉判读诊断敏感度100%、特异度97%,与PiB和FBP完全一致。
  • 以全小脑为参考时,FBZ全局SUVr诊断AD的界值范围为0.99至1.38。

临床怎么用

  • FBZ PET诊断效能与PiB和FBP相当,Aβ定量相关性极佳;其皮质摄取高、白质结合低,有利于临床视觉判读。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aims to compare [18F]Florbetazine (FBZ, [18F]92) with [11C]Pittsburgh compound B (PiB) and [18F]Florbetapir (FBP) PET imaging to evaluate the diagnostic efficacy of FBZ and explore differences in topographical deposition patterns between FBZ and PiB/FBP. METHODS: Seventy-eight participants were included, with 40 in the FBZ-PiB subgroup (9 healthy controls [HCs], 9 with non-AD dementia, and 22 with AD) and 38 in the FBZ-FBP subgroup (10 HCs, 9 with non-AD dementia, 1 with mild cognitive impairment [MCI], and 18 with AD). All images were visually evaluated by two trained nuclear medicine physicians and quantitatively analyzed using global and regional standardized uptake value ratio (SUVr). RESULTS: Visual interpretation of FBZ scans achieved a diagnostic sensitivity of 100% and a specificity of 97%, with complete concordance with PiB and FBP. Positive FBZ PET scans showed higher gray matter uptake relative to white matter, closely resembling the cortical distribution of PiB but offering greater gray-to-white matter contrast compared to both PiB (1.19(0.17) vs. 1.11(0.15), P < 0.001) and FBP (1.27(0.24) vs. 0.86(0.13), P < 0.001). The global SUVr for all three radiotracers demonstrated perfect diagnostic accuracy for AD, with a cut-off range of 0.99 to 1.38 for FBZ when using the whole cerebellum as a reference. The global SUVr of FBZ strongly correlated with PiB (slope = 0.94, r = 0.99, P < 0.001) and FBP (slope = 1.74, r = 0.95, P < 0.001). CONCLUSION: FBZ PET imaging exhibits comparable diagnostic efficacy to PiB and FBP, with excellent correlation for Aβ quantification. Its high cortical uptake and low white matter binding favors visual interpretation in clinical practice. CLINICAL TRIAL REGISTRATION: NCT06141356. Registered November 2023. https://clinicaltrials.gov/search?term=NCT06141356 .

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Wu M, Li Y, Liang M, et al. The diagnostic performance of [18F]Florbetazine in Alzheimer's disease: a head-to-head comparison to [11C]PiB and [18F]Florbetapir. Eur J Nucl Med Mol Imaging. 2025. PMID: 40183954. doi:10.1007/s00259-025-07233-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。